Article
SARS-CoV-2 Delta–Omicron Recombinant Viruses, United States
21 Jun 2022
Abstract excerpt
E merging variants of SARS-CoV-2 are character- ized and monitored closely by national genomic surveillance. In addition to sequencing efforts from US public health, academic, and commercial laboratories, the Centers for Disease Control and Prevention (CDC) collects and sequences SARS-CoV-2 specimens from 64 partners across state, tribal, local, and territorial public health agencies through the National...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
